Myriad Genetics Inc (MYGN)
Payables turnover
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cost of revenue (ttm) | US$ in thousands | 678,200 | 733,300 | 741,500 | 922,000 | 824,000 | 674,700 | 578,700 | 502,900 | 556,600 | 585,300 | 614,900 | 666,100 | 579,100 | 662,300 | 652,200 | 664,100 | 706,500 | 616,200 | 615,600 | 610,100 |
Payables | US$ in thousands | 33,300 | 33,100 | 25,800 | 33,900 | 39,800 | 36,500 | 28,800 | 29,600 | 21,700 | 27,100 | 29,600 | 15,700 | 28,500 | 20,800 | 19,100 | 21,700 | 30,300 | 21,000 | 24,000 | 33,300 |
Payables turnover | 20.37 | 22.15 | 28.74 | 27.20 | 20.70 | 18.48 | 20.09 | 16.99 | 25.65 | 21.60 | 20.77 | 42.43 | 20.32 | 31.84 | 34.15 | 30.60 | 23.32 | 29.34 | 25.65 | 18.32 |
June 30, 2024 calculation
Payables turnover = Cost of revenue (ttm) ÷ Payables
= $678,200K ÷ $33,300K
= 20.37
Myriad Genetics Inc's payables turnover ratio has fluctuated over the past several quarters. The ratio measures how efficiently the company is managing its accounts payable by looking at how many times a company pays off its suppliers during a period.
From December 2019 to March 2020, the payables turnover ratio increased steadily from 18.32 to 34.15, indicating that Myriad Genetics was managing its payables more efficiently during this period. However, this high ratio was not sustained, as it decreased in the following quarters.
From September 2020 to December 2021, the ratio remained relatively stable, ranging from 20.09 to 31.84. This suggests that the company was maintaining a consistent level of efficiency in managing its payables during this time.
The most recent data shows a decrease in the payables turnover ratio, dropping from 22.15 in March 2024 to 20.37 in June 2024. This could indicate that Myriad Genetics is taking longer to pay off its suppliers compared to the previous quarter.
Overall, the trend in the payables turnover ratio for Myriad Genetics Inc shows some variability, but the company has demonstrated the ability to efficiently manage its accounts payable, with occasional fluctuations in performance. It is important for the company to monitor this ratio to ensure effective management of its payables and maintain positive relationships with its suppliers.
Peer comparison
Jun 30, 2024